Sale!

CAV3 Gene Limb-girdle muscular dystrophy autosomal dominant type 1C Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CAV3 gene limb-girdle muscular dystrophy autosomal dominant type 1C genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CAV3 gene, which are associated with limb-girdle muscular dystrophy type 1C (LGMD1C). LGMD1C is a rare form of muscular dystrophy that affects the voluntary muscles around the hips and shoulders (the limb-girdle muscles). This condition is characterized by progressive muscle weakness and wasting, typically beginning in late childhood or adulthood. The test involves analyzing the patient’s DNA to detect any genetic alterations in the CAV3 gene that might lead to the development of LGMD1C. This information is crucial for confirming a diagnosis, understanding the prognosis, and making informed decisions about management and treatment options. The cost of the test at DNA Labs UAE is 4400 AED, offering a reliable resource for individuals and families seeking genetic insights into this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CAV3 Gene Limb-girdle muscular dystrophy autosomal dominant type 1C Genetic Test

Test Details

The CAV3 gene is associated with Limb-girdle muscular dystrophy, autosomal dominant type 1C (LGMD1C). This is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the hips and shoulders.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the CAV3 gene, to identify potential genetic variants or mutations associated with a specific condition. This type of testing is more comprehensive and can provide more detailed information compared to traditional genetic testing methods.

By performing an NGS genetic test for LGMD1C, healthcare providers can identify specific mutations or variants in the CAV3 gene that may be causing the condition. This information can be used for accurate diagnosis, genetic counseling, and potentially targeted treatment options.

It is important to note that genetic testing for LGMD1C should be performed by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate guidance and support.

Test Name: CAV3 Gene Limb-girdle muscular dystrophy autosomal dominant type 1C Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for CAV3 Gene Limb-girdle muscular dystrophy, autosomal dominant type 1C NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Limb-girdle muscular dystrophy, autosomal dominant type 1C

Test Name CAV3 Gene Limb-girdle muscular dystrophy autosomal dominant type 1C Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CAV3 Gene Limb-girdle muscular dystrophy, autosomal dominant type 1C NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CAV3 Gene Limb-girdle muscular dystrophy, autosomal dominant type 1C
Test Details

The CAV3 gene is associated with Limb-girdle muscular dystrophy, autosomal dominant type 1C (LGMD1C). This is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the hips and shoulders.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the CAV3 gene, to identify potential genetic variants or mutations associated with a specific condition. This type of testing is more comprehensive and can provide more detailed information compared to traditional genetic testing methods.

By performing an NGS genetic test for LGMD1C, healthcare providers can identify specific mutations or variants in the CAV3 gene that may be causing the condition. This information can be used for accurate diagnosis, genetic counseling, and potentially targeted treatment options.

It is important to note that genetic testing for LGMD1C should be performed by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate guidance and support.